Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

• Status: NOT_YET_RECRUITING
• Trial end date: 2028-10-01

Summary

Based on the Phase I trial completed by the sponsor, the Phase II clinical trial aims to investigate the effectiveness and safety of image guidance volume-modulated arc radiation therapy concurrently with Nab-Paclitaxel plus Cisplatin for patients with locally advanced cervical cancer.

• Phase: PHASE2

Details

• Lead Sponsor: Peking University Third Hospital
• Collaborators: Affiliated Hospital of Hebei University; Hebei Medical University Fourth Hospital; Jilin Provincial Tumor Hospital
• Treatments: Cisplatin; Injections; Paclitaxel; Radiotherapy; Taxes